242 related articles for article (PubMed ID: 33937014)
1. Systematic Chromatin Accessibility Analysis Based on Different Immunological Subtypes of Clear Cell Renal Cell Carcinoma.
Zhang S; Zheng W; Jiang D; Xiong H; Liao G; Yang X; Ma H; Li J; Qiu M; Li B; Sun C; Zhao J; Wang L; Pang J
Front Oncol; 2021; 11():575425. PubMed ID: 33937014
[TBL] [Abstract][Full Text] [Related]
2. Development and implementation of a prognostic model for clear cell renal cell carcinoma based on heterogeneous TLR4 expression.
Zhou Q; Sun Q; Shen Q; Li X; Qian J
Heliyon; 2024 Feb; 10(4):e25571. PubMed ID: 38380017
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma.
Teng ZH; Li WC; Li ZC; Wang YX; Han ZW; Zhang YP
Front Oncol; 2022; 12():1094248. PubMed ID: 36620592
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
Jiang H; Chen H; Wan P; Chen N
Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M
Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933
[TBL] [Abstract][Full Text] [Related]
6. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties.
Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X
Front Immunol; 2023; 14():1191365. PubMed ID: 37426638
[TBL] [Abstract][Full Text] [Related]
7. ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration.
Tang YF; Qiao B; Huang YB; Wang M
Front Mol Biosci; 2023; 10():1202524. PubMed ID: 37795220
[No Abstract] [Full Text] [Related]
8. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
Front Immunol; 2021; 12():734646. PubMed ID: 34795663
[TBL] [Abstract][Full Text] [Related]
9. Pyroptosis Regulators and Tumor Microenvironment Infiltration Characterization in Clear Cell Renal Cell Carcinoma.
Zhang X; Wei X; Wang Y; Wang S; Ji C; Yao L; Song N
Front Oncol; 2021; 11():774279. PubMed ID: 35070978
[TBL] [Abstract][Full Text] [Related]
10. Adipogenic Transdifferentiation and Regulatory Factors Promote the Progression and the Immunotherapy Response of Renal Cell Carcinoma: Insights From Integrative Analysis.
Wang S; Wei X; Ji C; Wang Y; Zhang X; Cong R; Song N
Front Oncol; 2022; 12():781932. PubMed ID: 35356208
[TBL] [Abstract][Full Text] [Related]
11. Survival Prognosis, Tumor Immune Landscape, and Immune Responses of PPP1R18 in Kidney Renal Clear Cell Carcinoma and Its Potentially Double Mechanisms.
Wang Y; Liu S; Chen Y; Zhu B; Xing Q
World J Oncol; 2022 Feb; 13(1):27-37. PubMed ID: 35317332
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
14. Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma.
Sun X; Liu P
Front Oncol; 2023; 13():1073941. PubMed ID: 36816967
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Wang S; Chen S; Ying Y; Ma X; Shen H; Li J; Wang X; Lin Y; Liu B; Zheng X; Xie L
Front Cell Dev Biol; 2021; 9():676142. PubMed ID: 34291048
[TBL] [Abstract][Full Text] [Related]
16. Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma.
Qin H; Wang T; Zhang H
Front Genet; 2022; 13():906113. PubMed ID: 35846133
[No Abstract] [Full Text] [Related]
17. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
Front Genet; 2020; 11():810. PubMed ID: 33014010
[TBL] [Abstract][Full Text] [Related]
18. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
19. High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma.
Yang Y; Ye F; Xia T; Wang Q; Du J
BMC Cancer; 2022 Dec; 22(1):1355. PubMed ID: 36575439
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of chromatin accessibility in human cancers.
Liu Y
Oncotarget; 2020 May; 11(18):1666-1678. PubMed ID: 32405341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]